Physician-Researcher & Yale MPH Candidate

Jananthan Paramsothy, M.D.

Physician-researcher with 10+ years across Phase I–III clinical trials, inpatient medicine, and health informatics. Bridging clinical rigor with data-driven innovation.

school Yale MPH — Health Informatics (4.00)
medical_services M.D. — ECFMG Certified
science Founder & Study Investigator — HeallyConnect
Dr. Jananthan Paramsothy — Professional Headshot

Core Competencies

Spanning clinical trial leadership, pharmacovigilance, health informatics, and regulatory strategy.

clinical_notes

Clinical Trials

Phase I-III design & execution, medical monitoring, IND/NDA regulatory strategy.

health_and_safety

Pharmacovigilance

SAE/TME/SUSAR reporting, blinded data review, signal detection, DMC processes.

analytics

Health Informatics

Predictive analytics, RWD/RWE, computational drug discovery, Python/SQL pipelines.

gavel

Regulatory & IRB

FDA/ICH/GCP compliance, HIPAA & 42 CFR Part 2, IRB protocol development.

Career Highlights

From frontline medicine to clinical research leadership.

Full Experience arrow_forward
May 2025 — Present

Founder & Study Investigator — HeallyConnect

Yale School of Public Health | Digital Health Research Study

Jul 2024 — Feb 2025

Senior Research Associate — Medical Monitoring

Saint Michael Medical Center | 8 Phase III HIV Trials (Pfizer, J&J, AbbVie, Merck)

May 2015 — May 2017

Senior Medical Officer — Anesthesiology & Critical Care

Vavuniya District General Hospital, Sri Lanka

Education & Credentials

2024 — 2026

Executive Master of Public Health

Health Informatics Track | GPA: 4.00

Yale School of Public Health, New Haven, CT

2007 — 2014

Doctor of Medicine (M.D.)

Faculty of Medicine, University of Jaffna, Sri Lanka

Certifications & Licensure

ECFMG Certified USMLE Step 1, 2 CK, 3 — All Passed ACGME Residency Training ICH/GCP Trained ACLS & BLS CITI Human Subjects Research

Memberships

AMA APHA ACP Sri Lankan Medical Association

Let's collaborate.

Open to clinical research, health informatics, and medical-technology partnerships.